# Selank

Canonical source: https://retacompare.com/encyclopedia/selank

Anxiolytic peptide that modulates GABA, serotonin and BDNF in animal models without sedation.

Reference facts

Also known asTP-7CategoryNootropic & CognitiveMechanism of actionAnxiolytic peptide that modulates GABA, serotonin and BDNF in animal models without sedation.TargetsGABA-A allosteric modulation (indirect), BDNF expressionIndications under research or approvedApproved Russia (generalized anxiety); not US-approvedRegulatory status (reference entry)Not FDA-approvedHalf-lifeSeveral hours (intranasal)SequenceTKPRPGPSequence notesHeptapeptide. Synthetic analog of the immunomodulator tuftsin (TKPR) with a stabilizing PGP tail.Molecular weight (Da)752Originator / sponsorOriginally Institute of Molecular Genetics, MoscowFirst reported1991
    Primary References

Kost et al., Neuroscience 2015 (Selank pharmacology)


    Explore research articles about Selank


    This is an educational reference, not medical advice. Research findings do not establish safety or efficacy for self-administration. Consult the primary sources for study populations, limitations, and current regulatory status.

## Sources

- Kost et al., Neuroscience 2015 (Selank pharmacology): https://pubmed.ncbi.nlm.nih.gov/26341738/